ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 37 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 2,686 | -83.1% | 0.00% | – |
| Q3 2019 | $5,000 | +150.0% | 15,940 | +64.9% | 0.00% | – |
| Q2 2019 | $2,000 | -88.2% | 9,669 | -81.7% | 0.00% | – |
| Q1 2019 | $17,000 | -73.4% | 52,896 | -0.7% | 0.00% | – |
| Q4 2018 | $64,000 | -80.4% | 53,276 | -69.7% | 0.00% | – |
| Q3 2018 | $327,000 | +5.5% | 175,568 | +26.7% | 0.00% | – |
| Q2 2018 | $310,000 | +425.4% | 138,606 | +411.9% | 0.00% | – |
| Q1 2018 | $59,000 | – | 27,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 12,073,080 | $2,778,000 | 0.03% |
| jvl associates llc | 58,500 | $13,000 | 0.01% |
| RETIREMENT INCOME SOLUTIONS, INC | 26,703 | $6,000,000 | 0.00% |
| Paloma Partners Management Co | 197,200 | $45,000 | 0.00% |
| JANE STREET GROUP, LLC | 50,586 | $12,000 | 0.00% |
| UBS Group AG | 42,559 | $10,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 5,454 | $1,255,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 63,915 | $14,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 31,293 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 326,583 | $75,000 | 0.00% |